Position Statement on Genital Surgery in Individuals with Differences of Sex Development (DSD)/Intersex Traits

Read More

Balancing the Benefits and Harms of Thyroid Cancer Surveillance in Survivors of Childhood, Adolescent and Young Adult Cancer: Recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration with the PanCareSurFup Consortium (Cancer Treat Rev. 2018)

Read More

An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of PCOS in Adolescence (HRP 2017)

An International Consortium Update on the Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence,

Read More

Revised D&T Statement on GnRHa and Prolonged QT 2017

PES Drugs and Therapeutics Committee presents a statement on the Risk of Prolonged QT Interval with Gonadotropin Releasing Hormone Agonists.

Read More

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Cardiovascular Disease and Associated Risk Factors Working Group Report

Read More

Diagnosis and Management of Silver-Russell Syndrome: 1st International Consensus Statement (Nat. Rev. Endocrinology 2017)

The first international consensus statement on diagnosis and management of Silver–Russell syndrome presented by 41 task force members from 16 countries.

Read More

Global Consensus Recommendations on Prevention and Management of Nutritional Rickets

This consensus document defines nutritional rickets and its diagnostic criteria and describes the clinical management of rickets and osteomalacia. Risk factors, particularly in mothers and infants,…

Read More

NCI, NHLBI/PBMTC First International Conference on Late Effects After Pediatric Hematopoietic Cell Transplantation: Endocrine Challenges-Thyroid Dysfunction, Growth Impairment, Bone Health, & Reproductive Risks

Read More

Consensus on Use of Gonadotropin-Releasing Hormone Analogs in Children (Pediatrics 2009)

An International Consensus Statement on the Use of Gonadotropin-Releasing Hormone Analogs in Children.

Read More

Changes in Recombinant Human Growth Hormone Prescribing Information (PES D & T Committee 2008)

Members of the Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society describe the changes in the prescribing information for the different forms of
rhGH.

Read More